Evidence map›Paper›PMID 30612693›Full record

ArticleAmerican journal of human genetics2019

De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies.

Konrad Platzer, Heinrich Sticht, Stacey L Edwards, William Allen, Kaitlin M Angione, Maria T Bonati, Campbell Brasington, Megan T Cho, Laurie A Demmer, Tzipora Falik-Zaccai and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Characterization of a novel inherited splice-site variant inBiochemistry and biophysics reports · 2026
    Article
  5. Article
  6. Article
  7. medRxiv : the preprint server for health sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Mechanism and regulation of kinesin motors.Nature reviews. Molecular cell biology · 2025
    Review
  12. Article
  13. Article
  14. Autism candidate genebioRxiv : the preprint server for biology · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 6 countries.

Konrad PlatzerInstitute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig 04103, Germany. Electronic address: konrad.platzer@medizin.uni-leipzig.de.
Heinrich StichtInstitute of Biochemistry, Emil-Fischer Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany.
Stacey L EdwardsGenetic Models of Disease Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
William AllenDepartment of Genetics, Fullerton Genetics Center, Asheville, NC 28803, USA.
Kaitlin M AngioneDepartment of Pediatrics, Section of Clinical Genetics and Metabolism, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Maria T BonatiClinic of Medical Genetics, IRCCS Istituto Auxologico Italiano, Milan 20149, Italy.
Campbell BrasingtonDepartment of Pediatrics, Clinical Genetics, Levine Children's Hospital at Carolina Healthcare System, Charlotte, NC 28203, USA.
Megan T ChoGeneDx, Gaithersburg, MD 20877, USA.
Laurie A DemmerDepartment of Pediatrics, Clinical Genetics, Levine Children's Hospital at Carolina Healthcare System, Charlotte, NC 28203, USA.
Tzipora Falik-ZaccaiInstitute of Human Genetics, Galilee Medical Center, Nahariya 22100, Israel; The Azrieli School of Medicine, Bar-Ilan University, Safed 1311502, Israel.
Candace N GambleDepartment of Pediatrics, University of Texas Health Medical School, Houston, TX 77030, USA.
Yorck HellenbroichInstitute of Human Genetics, University of Lübeck, Lübeck 23562, Germany.
Maria IasconeLaboratorio di Genetica Medica, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo 24127, Italy.
Fernando KokMendelics Genomic Analysis, São Paulo 04013-000, Brazil.
Sonal MahidaDepartment of Neurology, Kennedy Krieger Institute, the Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Hanna MandelInstitute of Human Genetics, Galilee Medical Center, Nahariya 22100, Israel.
Thorsten MarquardtDepartment of Pediatrics, University Hospital Münster, Münster 48149, Germany.
Kirsty McWalterGeneDx, Gaithersburg, MD 20877, USA.
Bianca PanisDepartment of Pediatrics, Zuyderland Medical Center, Heerlen and Sittard 6419, the Netherlands.
Alexander PeplerCeGaT GmbH and Praxis für Humangenetik Tübingen, Tübingen 72076, Germany.
Hailey PinzDivision of Medical Genetics, Department of Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO 63104, USA.
Luiza RamosMendelics Genomic Analysis, São Paulo 04013-000, Brazil.
Deepali N ShindeDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, CA 92656, USA.
Constance Smith-HicksDepartment of Neurology, Kennedy Krieger Institute, the Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Alexander P A StegmannDepartment of Clinical Genetics and School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6229, the Netherlands.
Petra StöbeCeGaT GmbH and Praxis für Humangenetik Tübingen, Tübingen 72076, Germany.
Constance T R M StumpelDepartment of Clinical Genetics and School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6229, the Netherlands.
Carolyn WilsonDepartment of Genetics, Fullerton Genetics Center, Asheville, NC 28803, USA.
Johannes R LemkeInstitute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig 04103, Germany.
Nataliya Di DonatoInstitute for Clinical Genetics, Carl Gustav Carus Faculty of Medicine, TU Dresden, Dresden 01307, Germany.
Kenneth G MillerGenetic Models of Disease Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Rami JamraInstitute of Human Genetics, University of Leipzig Hospitals and Clinics, Leipzig 04103, Germany.
University Hospital Leipzig · DECeGaT (Germany) · DEFullerton College · USGenomic (Brazil) · BRMaastricht University · NLOklahoma Medical Research Foundation · USAmbry Genetics (United States) · USBar-Ilan University · ILCarolinas Healthcare System · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEIRCCS Istituto Auxologico Italiano · ITJohns Hopkins University · USKennedy Krieger Institute · USLevine Children's Hospital · USOspedale Papa Giovanni XXIII · ITSaint Louis University · USThe University of Texas Health Science Center at Houston · USTU Dresden · DEUniversity Hospital Münster · DEUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using exome sequencing, we have identified de novo variants in MAPK8IP3 in 13 unrelated individuals presenting with an overlapping phenotype of mild to severe intellectual disability. The de novo variants comprise six missense variants, three of which are recurrent, and three truncating variants. Brain anomalies such as perisylvian polymicrogyria, cerebral or cerebellar atrophy, and hypoplasia of the corpus callosum were consistent among individuals harboring recurrent de novo missense variants. MAPK8IP3 has been shown to be involved in the retrograde axonal-transport machinery, but many of its specific functions are yet to be elucidated. Using the CRISPR-Cas9 system to target six conserved amino acid positions in Caenorhabditis elegans, we found that two of the six investigated human alterations led to a significantly elevated density of axonal lysosomes, and five variants were associated with adverse locomotion. Reverse-engineering normalized the observed adverse effects back to wild-type levels. Combining genetic, phenotypic, and functional findings, as well as the significant enrichment of de novo variants in MAPK8IP3 within our total cohort of 27,232 individuals who underwent exome sequencing, we implicate de novo variants in MAPK8IP3 as a cause of a neurodevelopmental disorder with intellectual disability and variable brain anomalies.

Indexed as

MutationAdaptor Proteins, Signal TransducingAdolescentAnimalsBrainCaenorhabditis elegansChildChild, PreschoolComputer SimulationCRISPR-Cas SystemsExome SequencingFemaleHumansIntellectual DisabilityLocomotionLysosomesAdaptor Proteins, Signal TransducingMAPK8IP3 protein, humanNerve Tissue Proteinsbrain anomaliesde novodevelopmental delayintellectual disabilityMAPK8IP3neurodevelopmental disorderpolymicrogyria

Identifiers

PMID30612693
PMCPMC6369540
OpenAlexW2907989158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.